Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canopy Growth Co. stock logo
CGC
Canopy Growth
$11.00
+11.0%
$7.90
$2.76
$19.20
$1.11B1.111.82 million shs34.56 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.02
+4.1%
$2.52
$1.64
$3.14
$1.15B1.113.08 million shs7.14 million shs
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$8.65
-4.6%
$9.46
$2.41
$12.22
$637.33M2.721.79 million shs1.05 million shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$48.46
+1.1%
$46.34
$41.45
$69.60
$923.21M0.9480,369 shs61,998 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canopy Growth Co. stock logo
CGC
Canopy Growth
+11.00%+11.56%+64.18%+187.96%+4.76%
Cronos Group Inc. stock logo
CRON
Cronos Group
+4.14%+5.96%+23.77%+33.04%+72.57%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-4.63%-5.15%-12.45%+75.81%+174.60%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
+1.04%+4.62%+12.25%-1.82%-23.30%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.7725 of 5 stars
0.73.00.00.02.20.01.3
Cronos Group Inc. stock logo
CRON
Cronos Group
0.1306 of 5 stars
1.03.00.00.02.60.00.0
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
3.223 of 5 stars
4.54.00.00.01.90.80.6
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
3.8775 of 5 stars
1.35.00.03.03.31.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Canopy Growth Co. stock logo
CGC
Canopy Growth
1.33
Sell$4.87-55.76% Downside
Cronos Group Inc. stock logo
CRON
Cronos Group
2.00
Hold$3.00-0.66% Downside
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
3.00
Buy$17.67104.24% Upside
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
2.50
Moderate Buy$46.00-5.08% Downside

Current Analyst Ratings

Latest CRON, USNA, CGC, and MNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2024
Cronos Group Inc. stock logo
CRON
Cronos Group
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformer ➝ Outperformer$3.00 ➝ $3.50
5/13/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$29.00 ➝ $20.00
5/10/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $35.00
5/7/2024
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$48.00 ➝ $46.00
4/15/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/15/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$20.00
4/8/2024
Cronos Group Inc. stock logo
CRON
Cronos Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$2.00 ➝ $2.50
3/14/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/1/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
2/29/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$14.00 ➝ $15.00
2/22/2024
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$53.00 ➝ $48.00
(Data available from 5/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Canopy Growth Co. stock logo
CGC
Canopy Growth
$362.24M3.08N/AN/A$11.14 per share0.99
Cronos Group Inc. stock logo
CRON
Cronos Group
$87.24M13.22N/AN/A$2.81 per share1.07
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
N/AN/AN/AN/A$2.79 per shareN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$900.45M1.03$4.51 per share10.74$26.25 per share1.85

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Canopy Growth Co. stock logo
CGC
Canopy Growth
-$2.48B-$15.12N/AN/AN/A-326.75%-73.48%-27.82%6/27/2024 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
-$73.96M-$0.15N/A50.33N/A-61.31%-3.06%-2.97%8/13/2024 (Estimated)
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-$95.73M-$2.94N/AN/AN/AN/A-84.72%-59.00%8/1/2024 (Estimated)
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$63.79M$3.2115.1015.381.426.88%12.80%10.05%7/23/2024 (Estimated)

Latest CRON, USNA, CGC, and MNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 2024
Cronos Group Inc. stock logo
CRON
Cronos Group
-$0.01-$0.01N/A-$0.01$24.30 million$25.29 million      
2/29/2024Q4 2023
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A-$0.05-$0.05$0.02$25.15 million$23.92 million    
2/28/2024Q4 2023
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
-$0.48-$0.59-$0.11-$0.59N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Canopy Growth Co. stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.96
1.79
1.40
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
28.19
27.28
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
0.07
3.91
3.91
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/A
3.74
3.20

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Canopy Growth Co. stock logo
CGC
Canopy Growth
3.33%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
27.91%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
54.25%

Insider Ownership

CompanyInsider Ownership
Canopy Growth Co. stock logo
CGC
Canopy Growth
0.35%
Cronos Group Inc. stock logo
CRON
Cronos Group
1.96%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
2.11%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.33%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Canopy Growth Co. stock logo
CGC
Canopy Growth
1,621101.31 million100.96 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
356382.01 million374.52 millionOptionable
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
5770.27 million68.79 millionOptionable
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1,80019.05 million18.99 millionOptionable

CRON, USNA, CGC, and MNMD Headlines

Recent News About These Companies

USANA HR Executive Awarded for Excellence in his Field
Q1 2024 USANA Health Sciences Inc Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Canopy Growth logo

Canopy Growth

NASDAQ:CGC
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Cronos Group logo

Cronos Group

NASDAQ:CRON
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Mind Medicine (MindMed) logo

Mind Medicine (MindMed)

NASDAQ:MNMD
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
USANA Health Sciences logo

USANA Health Sciences

NYSE:USNA
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.